Images of cardiac ischemic injury showing identification of tissue at risk (dying ) but viable (at the reversible stage), enabling early clinical intervention. Notice that Oxy-17® TVI results in negative contrast.
Independent Study -2
Prinicipal Investigator Nathaniel Reichek, MD
Allegheny General Hospital, Pittsburgh, PA
|
|
|
|
|
|
| |
For inquires to procure and work with "OXY-17® PLEASE CALL (001)-845-426-0748 or email us. We are presently collaborating with various investigators and welcome your interest
Independent Study -3
Principal Investigator: Drs. Michael Moseley & Alex deCrespigny
Stanford University Medical School, Lukas MRS Center, Palo Alto,CA
. |
|
Rockland Technimed Ltd.
Maratha House, 3 Larissa Court, Airmont, NY USA
Telephone: 001-(845)-426-3406, Fax -001- (845)-426-1109
Email - info@technimed.com Webmaster - webmaster@technimed.com
Copyright © 1999-2007 Rockland Technimed Ltd. All rights reserved.
|
